◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Innovotech Inc.

IOT.V TSXV Healthcare Edmonton, Canada
Loading stock data...
Stock Performance
Price History
- Drag to select time range -
Market Data
Market Cap 13.5M
P/E Ratio 26.00
52-Week High -
52-Week Low -
Avg Volume -
Beta -
Forward P/E -
Dividend Yield -
EV/Revenue -
Price/Book -
Business Overview

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

Healthcare Biotechnology TSXV
Key Financial Metrics
2.2M
Revenue
224,735
Net Income
C$0.01
EPS (Diluted)
-283,933
Free Cash Flow
Profitability
Gross Margin 50.6%
Operating Margin 2.2%
Net Profit Margin 10.2%
EBITDA 286,357
Returns & Efficiency
Return on Assets (ROA) 7.0%
Return on Equity (ROE) 8.8%
Dividend Yield -
Payout Ratio -
Financial Health
Total Assets 3.2M
Total Debt -
Debt to Equity -
Current Ratio 3.98
Company Info
IndustryBiotechnology
HQEdmonton, Canada
Fiscal Year End1735603200
CurrencyCAD
Websiteinnovotech.ca
Peers
7.9B
P/E: --
2.5B
P/E: 12.0
2.5B
P/E: 23.7
2.2B
P/E: 53.2
1.4B
P/E: 24.1
1.2B
P/E: --
1.1B
P/E: --
631.8M
P/E: --
Insider Activity
Sentiment Bullish
Shares Bought 4,605,184
Shares Sold 0
Total Transactions 58
SEDAR+ Filings
View All Filings
5
Annual Reports
27
Quarterly Reports
34
MD&A
70
News Releases
18
Governance
70
Certifications
38
Other
Interactive Charts
Company Profile
General Information
Company NameInnovotech Inc.
TickerIOT.V
ExchangeTSXV
SectorHealthcare
IndustryBiotechnology
HeadquartersEdmonton, Canada
Fiscal Year End1735603200
CurrencyCAD
Websiteinnovotech.ca
Financial Summary
Market Cap13.5M
Revenue2.2M
Net Income224,735
P/E Ratio26.00
EPS (Diluted)C$0.01
Net Margin10.2%
ROE8.8%
Dividend YieldN/A
Business Description
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.
NEWS
Loading news...
TRENDING
Loading...